INTERNATIONAL PATENT: EAGLE PHARMACEUTICALS, INC. FILES APPLICATION FOR "USE OF REMIMAZOLAM FOR PEDIATRIC SEDATION"

GENEVA, Feb. 26 -- EAGLE PHARMACEUTICALS, INC. (50 Tice BoulevardSuite 315Woodcliff Lake, NJ 07677) filed a patent application (PCT/US2024/041709) for "USE OF REMIMAZOLAM FOR PEDIATRIC SEDATION" on Aug 09, 2024. With publication no. WO/2025/038446, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BICHAJIAN, Lynn (50 Tice BoulevardSuite 315Woodcliff Lake, NJ 07677)

Abstract: The application is directed to methods of sedating a pediatric subject by administering intravenously to the subject remimazolam, or a pharmaceutica...